Unknown

Dataset Information

0

Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration.


ABSTRACT: Preclinical studies have demonstrated that a single injection of an adeno-associated virus (AAV) vector into the cerebrospinal fluid (CSF) can achieve widespread gene transfer throughout the central nervous system. Successfully translating this approach to humans requires identifying factors that influence AAV distribution in the CSF so that optimal parameters can be replicated in the clinic. In the context of developing a motor neuron-targeted gene therapy for spinal muscular atrophy, we conducted studies in nonhuman primates to evaluate the impact of injection volume on spinal cord transduction after AAV delivery via lumbar puncture. Lumbar injection of an AAVhu68 vector targeted motor neurons throughout the spinal cord, but only in juvenile nonhuman primates administered large injection volumes, equivalent to about half of the total CSF volume. Upon repeating this study with clinically relevant injection volumes and larger animals, we found that lumbar puncture failed to achieve significant transduction of the spinal cord. In contrast, vector administered into the cisterna magna distributed reproducibly throughout the spinal cord in both juvenile and adult animals. These findings highlight the challenges of translating AAV delivery via lumbar puncture to humans and suggest that delivery into the cisterna magna may represent a more feasible alternative.

SUBMITTER: Hinderer C 

PROVIDER: S-EPMC7218226 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Translational Feasibility of Lumbar Puncture for Intrathecal AAV Administration.

Hinderer Christian C   Katz Nathan N   Dyer Cecilia C   Goode Tamara T   Johansson Julia J   Bell Peter P   Richman Laura L   Buza Elizabeth E   Wilson James M JM  

Molecular therapy. Methods & clinical development 20200418


Preclinical studies have demonstrated that a single injection of an adeno-associated virus (AAV) vector into the cerebrospinal fluid (CSF) can achieve widespread gene transfer throughout the central nervous system. Successfully translating this approach to humans requires identifying factors that influence AAV distribution in the CSF so that optimal parameters can be replicated in the clinic. In the context of developing a motor neuron-targeted gene therapy for spinal muscular atrophy, we conduc  ...[more]

Similar Datasets

| S-EPMC3308035 | biostudies-literature
| S-EPMC5072681 | biostudies-literature
| S-EPMC3618620 | biostudies-literature
| S-EPMC7997047 | biostudies-literature
| S-EPMC8368585 | biostudies-literature
| S-EPMC4245872 | biostudies-literature
| S-EPMC8521568 | biostudies-literature
| S-EPMC5454130 | biostudies-literature
| S-EPMC7820377 | biostudies-literature
| S-EPMC5699954 | biostudies-literature